[Cite as http://purl.org/au-research/grants/nhmrc/1072476]
Dr David Ascher
Brief description The spread of cancer throughout the body, metastasis, is the major cause of death from cancer. The MET receptor plays a crucial role in over 60% of all metastases and several approaches to block its activity are currently in clinical trials. This project will use a new approach to develop small molecule inhibitors that block the MET receptor from interacting with another protein, HGF/SF. Small molecules that block this interaction will be highly effective treatments against metastatic cancers.
Funding Amount $AUD 353,866.28
Funding Scheme Early Career Fellowships
CJ Martin Biomedical ECF